Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),

Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +54 more
Jan 23, 2023

Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)

Active, not recruiting
Has Results
  • Gastric Cancer
  • +2 more
  • BMS-986213
  • +4 more
  • Clovis, California
  • +77 more
Jan 9, 2023

Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

Recruiting
  • Gastric Cancer
  • +8 more
  • Scottsdale, Arizona
  • +9 more
Dec 22, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

Active, not recruiting
  • Advanced Cancer
  • +16 more
  • Scottsdale, Arizona
  • +3 more
Dec 22, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Gastric Cancer, Hepatocellular Carcinoma Trial in Beverly Hills, Los Angeles, Torrance (Telatinib, Keytruda)

Recruiting
  • Gastric Cancer
  • Hepatocellular Carcinoma
  • Beverly Hills, California
  • +3 more
Sep 1, 2022

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Gastric Cancer Trial in China, Korea, Republic of, United States (IDX-1197+XELOX, IDX-1197+Irinotecan)

Recruiting
  • Gastric Cancer
  • Los Angeles, California
  • +11 more
Aug 7, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +15 more
  • Gilbert, Arizona
  • +4 more
Jun 21, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (Minnelide™Capsules)

Recruiting
  • Advanced Cancer
  • +9 more
  • Birmingham, Alabama
  • +6 more
Apr 4, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Esophageal Cancer, Gastric Cancer Trial in United States (Afatinib and Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Afatinib and Paclitaxel
  • Los Angeles, California
  • +8 more
Mar 18, 2022

Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

Completed
Has Results
  • Gastric Cancer
  • Los Angeles, California
  • +33 more
Feb 18, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-ADC)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Feb 10, 2022

Early Onset and Familial Gastric Cancer Registry

Active, not recruiting
  • Gastric Cancer
  • questionnaires
  • Los Angeles, California
  • +9 more
Feb 9, 2022

Advanced Solid Tumor, Gastric Cancer, Pancreas Cancer Trial in Los Angeles (TORL-2-307-MAB)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
    UCLA - JCCC Clinical Research Unit
Jan 24, 2022